4.6 Article

Clinical, histopathologic, and immunophenotypic features of lymphomatoid papulosis with CD8 predominance in 14 pediatric patients

Journal

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
Volume 61, Issue 6, Pages 993-1000

Publisher

MOSBY-ELSEVIER
DOI: 10.1016/j.jaad.2009.05.014

Keywords

CD8 disorders; immunophenotypic features; lymphomatoid papulosis; pediatric patients; T-cell receptor gene rearrangement

Categories

Ask authors/readers for more resources

Background Lymphomatoid papulosis (AP) is a cyclic papulonodular eruption that is clinically benign and histologically malignant. Association with hematologic neoplasias has been reported in 5% to 20% of all cases. Objective: We sought to review the clinical and histopathologic features of LyP in pediatric patients. Methods:We searched for the records of all patients with a clinical and histopathologic diagnosis of LyP seen at our clinic from January 1991 through April 2008. The cases of pediatric patients (aged < 20 years), were reviewed in detail. Results: Of 123 patients with LyP identified, 14 (11%) were in the pediatric age group. Most were male (64%); mean age of onset was 12 years. Type A LyP was identified in 12 patients, one patient had type B, and none had type C (type not determined in one case). Ten cases showed CD8 predominance by immunohistochemistry. T-cell intracytoplasmic antigen staining was positive in 3 cases of CD8(+) LyP type A and the one case of LyP type B. Lesional T-cell receptor gene rearrangement studies Were negative in 9 of 10 patients with LyP type A. The average follow-up time was 5.5 years. Lesions improved with treatment in most cases. and none of the cases were associated with hematologic malignancies. Limitations: This was a retrospective review. Conclusions: Among our pediatric patients, we noted a predominance of CD8(+) LyP, which does not seem to have an aggressive course. Further longitudinal studies are necessary to evaluate prognostic differences between CD4(+) and CD8(+) LyP and their biological significance. (J Am Acad Dermatol 2009;61:993-1000.)

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available